Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

The pharmaceutical industry as a medicines provider

4 references·11 citing·41 second hop

FromToDepth

this work references cited by second hop

References

1991Cost of innovation in the pharmaceutical industry763 cited
1999Access to Essential Drugs in Poor Countries396 cited
1995Success rates for new drugs entering clinical testing in the United States184 cited
2002IMPLICATIONS OF THE DOHA DECLARATION ON THE TRIPS AGREEMENT AND PUBLIC HEALTH104 cited

Cited by

2007Prices & availability of common medicines at six sites in India using a standard methodology.115 cited
2011Does the Market Share of Generic Medicines Influence the Price Level?85 cited
2008The Effect Of Regulation On Pharmaceutical Revenues: Experience In Nineteen Countries85 cited
2005GLOBAL TRADE AND PUBLIC HEALTH84 cited
2007TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines?70 cited
2013Generic Medicines: Solutions for a Sustainable Drug Market?67 cited
2011Promoting Global Cardiovascular Health45 cited
2006Fair trade for surgical instruments36 cited
2008“Backstage solidarity” in Spanish‐ and English‐written medical research papers: Publication context and the acknowledgment paratext23 cited
2018The Effect of Intellectual Property Rights Protection on the International Competitiveness of the Pharmaceutical Manufacturing Industry in China

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

12 cited

2023Evaluation of key indicators affecting the performance of healthcare supply chain agility12 cited